Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Pfizer leaves COVID product forecast unchanged

Ruchika Sharma29 July 2022 12:38 PM IST

Pfizer has been banking on sales of vaccine booster doses, including an Omicron-tailored version expected in the fall, to drive demand in the next few...

GSK Nucala application for COPD accepted for review in China

GSK gets USFDA nod for Benlysta for children with active lupus nephritis

Ruchika Sharma29 July 2022 11:39 AM IST

London: GSK plc has announced that the US Food and Drug Administration (USFDA) has approved Benlysta (belimumab) for the treatment of children aged 5...

ICMR invites bids from pharma companies for development of Monkeypox vaccine

Ruchika Sharma28 July 2022 5:09 PM IST

New Delhi: The National Institute of Virology (NIV) in Pune under ICMR has isolated the monkeypox virus from the clinical specimen of a patient which...

Indian Pharma firms likely to see muted revenue growth from US Generics Market in FY23: Ratings agency Icra

Ruchika Sharma28 July 2022 3:34 PM IST

New Delhi: Indian pharmaceutical firms are likely to witness muted revenue growth from the US generics market in FY23 due to price erosion pressure,...

AstraZeneca India introduces Chronic Kidney Disease Academy

Ruchika Sharma28 July 2022 1:45 PM IST

The certificate training course on CKD latest updates will train about 1000 primary care physicians through three interactive modules.

Biophore India Pharma arm gets CDSCO nod to manufacture, sell generic version of Pfizer COVID drug Paxlovid

Ruchika Sharma28 July 2022 12:32 PM IST

It was the first oral pill that has been approved by USFDA and with a better safety profile than subsequently approved oral therapies.

USFDA concludes inspection at Dr Reddys Labs Srikakulam API facility

Dr Reddy's Labs unveils Bortezomib for Injection in US

Ruchika Sharma28 July 2022 11:15 AM IST

Hyderabad: Drugmaker, Dr Reddy's Laboratories Ltd., has announced the launch of Bortezomib for Injection 3.5 mg, the generic equivalent of Velcade...

Pfizer, BioNTech sue CureVac in US over COVID vaccine patent claims

Ruchika Sharma27 July 2022 4:44 PM IST

Frankfurt: COVID-19 vaccine maker BioNTech said on Tuesday that it and partner Pfizer have filed a complaint with the U.S. District Court in...

Strides, Incepta partner to expand women health access with WHO prequalified contraceptive

Bharat Biotech, ExcellGene and University of Sydney ink pact to develop variant-proof COVID vaccine

Ruchika Sharma27 July 2022 2:30 PM IST

New Delhi: Swiss biologics contract development and manufacturing organisation ExcellGene SA on Tuesday said it has partnered with Bharat Biotech and...

In talks with Bavarian Nordic for import of monkeypox vaccine: Serum institute CEO

Ruchika Sharma27 July 2022 1:15 PM IST

Bavarian Nordic has already developed a vaccine against monkeypox and is available in different markets under brand names Jynneos, Imvamune or...

Sun Pharma to commercialise acne cream WINLEVI in Japan, Russia and 4 other territories

Ruchika Sharma27 July 2022 12:15 PM IST

A first-in-class topical androgen receptor inhibitor, WINLEVI was approved by the U.S. Food and Drug Administration (USFDA) in August 2020 for the...

Zydus Lifesciences bags USFDA nod for BP drug Bisoprolol Fumarate

Ruchika Sharma27 July 2022 11:25 AM IST

The drug will be manufactured at the group's formulation manufacturing facility at, SEZ, Ahmedabad, India.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok